Novanta (NOVTU) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Novanta (NOVTU) over the last 16 years, with Q3 2025 value amounting to $0.3.
- Novanta's EPS (Weighted Average and Diluted) fell 4339.62% to $0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.46, marking a year-over-year decrease of 1204.82%. This contributed to the annual value of $1.77 for FY2024, which is 1237.62% down from last year.
- Latest data reveals that Novanta reported EPS (Weighted Average and Diluted) of $0.3 as of Q3 2025, which was down 4339.62% from $0.12 recorded in Q2 2025.
- Novanta's 5-year EPS (Weighted Average and Diluted) high stood at $0.63 for Q3 2022, and its period low was $0.12 during Q2 2025.
- Over the past 5 years, Novanta's median EPS (Weighted Average and Diluted) value was $0.42 (recorded in 2022), while the average stood at $0.44.
- In the last 5 years, Novanta's EPS (Weighted Average and Diluted) surged by 6578.95% in 2022 and then crashed by 6842.11% in 2025.
- Novanta's EPS (Weighted Average and Diluted) (Quarter) stood at $0.39 in 2021, then increased by 7.69% to $0.42 in 2022, then decreased by 19.05% to $0.34 in 2023, then surged by 32.35% to $0.45 in 2024, then crashed by 33.33% to $0.3 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.3 in Q3 2025, compared to $0.12 in Q2 2025 and $0.59 in Q1 2025.